Avoid common mistakes on your manuscript.
Correction to: Diabetes Ther https://doi.org/10.1007/s13300-021-01064-4
In original article, there are few facts published incorrectly. The correct Table 4 is given below.
There are few corrections in the second paragraph under the Table 4.
“In the additional scenario considering severe and non-severe hypoglycaemic episodes, the total annual cost reached €2,951,884 and €2,309,089 for the cohort with SMBG and the FreeStyle Libre 2 system, respectively.”
“Cost savings with the use of the FreeStyle Libre 2 system as compared to SMBG would be up to €642,795 per year (− 21.8%) (Table 4).”
The original article has been updated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Oyagüez, I., Gómez-Peralta, F., Artola, S. et al. Correction to: Cost Analysis of FreeStyle Libre® 2 System in Type 2 Diabetes Mellitus Population. Diabetes Ther 12, 2263–2264 (2021). https://doi.org/10.1007/s13300-021-01093-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13300-021-01093-z